Related Experiment Video
Updated: Jun 17, 2026
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Predictors of efficacy after stereotactic radiosurgery for medial temporal lobe epilepsy
1Northern California Comprehensive Epilepsy Center, Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
Background:
Stereotactic radiosurgery (RS) is a promising treatment for intractable medial temporal lobe epilepsy (MTLE). However, the basis of its efficacy is not well understood.
Methods:
Thirty patients with MTLE were prospectively randomized to receive 20 or 24 Gy 50% isodose RS centered at the amygdala, 2 cm of the anterior hippocampus, and the parahippocampal gyrus. Posttreatment MRI was evaluated quantitatively for abnormal T2 hyperintensity and contrast enhancement, mass effect, and qualitatively for spectroscopic and diffusion changes. MRI findings were analyzed for potential association with radiation dose and seizure remission (Engel Ib or better outcome).
Results:
Despite highly standardized dose targeting, RS produced variable MRI alterations. In patients with multiple serial imaging, the appearance of vasogenic edema occurred approximately 9-12 months after RS and correlated with onset of seizure remission. Diffusion and spectroscopy-detected alterations were consistent with a mechanism of temporal lobe radiation injury mediated by local vascular insult and neuronal loss. The degree of these early alterations at the peak of radiographic response was dose-dependent and predicted long-term seizure remission in the third year of follow-up. Radiographic changes were not associated with neurocognitive impairments.
Conclusions:
Temporal lobe stereotactic radiosurgery resulted in significant seizure reduction in a delayed fashion which appeared to be well-correlated with structural and biochemical alterations observed on neuroimaging. Early detected changes may offer prognostic information for guiding management.
Insights
Stereotactic radiosurgery for epilepsy shows delayed seizure reduction, linked to neuroimaging changes. Early MRI findings predict long-term seizure remission, guiding patient management.
Area of Science:
- Neurology
- Neurosurgery
- Radiology
Background:
- Stereotactic radiosurgery (RS) is a potential treatment for intractable medial temporal lobe epilepsy (MTLE).
- The underlying mechanisms of RS efficacy in MTLE remain unclear.
Purpose of the Study:
- To investigate the neuroimaging changes following RS in MTLE patients.
- To correlate these changes with radiation dose and seizure remission.
Main Methods:
- Thirty MTLE patients were randomized to receive 20 or 24 Gy RS targeting specific medial temporal lobe structures.
- Posttreatment MRI assessed T2 hyperintensity, contrast enhancement, mass effect, spectroscopy, and diffusion changes.
- MRI findings were analyzed for association with radiation dose and seizure outcomes (Engel Ib or better).
Main Results:
- RS induced variable MRI alterations, with vasogenic edema appearing 9-12 months post-RS, correlating with seizure remission.
- Diffusion and spectroscopy changes suggested radiation injury via vascular insult and neuronal loss.
- Early dose-dependent radiographic changes predicted long-term seizure remission, without neurocognitive impairment.
Conclusions:
- Temporal lobe RS achieved delayed but significant seizure reduction.
- Observed neuroimaging alterations correlated with treatment efficacy.
- Early MRI changes may provide prognostic value for managing MTLE.
